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a  b  s  t  r  a  c  t
A-type  lamins  are components  of the  lamina  network  at the  nuclear  envelope,  which  mediates  nuclear
stiffness  and  anchors  chromatin  to  the  nuclear  periphery.  However,  A-type  lamins  are also  found  in
the  nuclear  interior.  Here  we review  the  roles  of the chromatin-associated,  nucleoplasmic  LEM protein,
lamina-associated  polypeptide  2  (LAP2)  in  the  regulation  of  A-type  lamins  in the  nuclear  interior.  The
lamin  A/C–LAP2  complex  may  be involved  in the  regulation  of the  retinoblastoma  protein-mediated
pathway and  other  signaling  pathways  balancing  proliferation  and  differentiation,  and  in the stabilizationuclear  envelope
uclear envelopathies
rogeria
elf-renewal
of  higher-order  chromatin  organization  throughout  the nucleus.  Loss  of  LAP2  in mice  leads  to  selective
depletion  of the  nucleoplasmic  A-type  lamin  pool,  promotes  the  proliferative  stem  cell  phenotype  of
tissue  progenitor  cells,  and  delays  stem  cell  differentiation.  These  ﬁndings  support  the  hypothesis  that
LAP2  and  nucleoplasmic  lamins  are regulators  of  adult  stem  cell function  and  tissue  homeostasis.  Finally,
we  discuss  potential  implications  of  this  concept  for deﬁning  the  molecular  disease  mechanisms  of lamin-
linked  diseases  such  as muscular  dystrophy  and  premature  aging  syndromes.© 2014  The  Authors.  Published  by  Elsevier  Ltd.  
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. Introduction
The nuclear lamina is a proteinaceous network in metazoan
ells that underlies the inner nuclear membrane (INM) and pro-
ides mechanical stability for the nuclear envelope (NE) (Fig. 1)
1–3]. It also fulﬁlls a plethora of functions in chromatin orga-
ization, gene expression and signaling during development and
issue maintenance [4–10]. The lamina network is formed by type
 intermediate ﬁlaments, the lamins [11–13], and a large num-
er of lamin-binding proteins of the INM [14,15]. Structurally and
unctionally, lamins are grouped into A- and B-type lamins [16].
he main B-type lamins, lamin B1 and lamin B2 are encoded by
MNB1 and LMNB2,  respectively, and at least one B-type lamin is
xpressed in most cells throughout development. A-type lamins
re encoded by the LMNA gene, giving rise to two major isoforms,
amin A and C, which are expressed later in development and
n a differentiation-dependent manner [17]. Importantly, B-type
amins are processed post-translationally to yield a C-terminally
arnesylated mature protein that is tightly associated with the INM
hrough its hydrophobic farnesyl group. In contrast, newly syn-
hesized pre-lamin A is also farnesylated during processing, but in
 ﬁnal maturation step a C-terminal peptide, including the farne-
yl group, is proteolytically cleaved, producing a non-farnesylated
ature lamin A [18–20]. Therefore, unlike B-type lamins, A-type
amins are less tightly linked to the INM and the lamina and are
lso found in a more mobile and dynamic pool throughout the
ucleoplasm [21–24]. However, the regulation and speciﬁc func-
ions of this dynamic, nucleoplasmic pool of A-type lamins are still
oorly understood. Recent studies revealed evidence for exciting
ovel functions of this nucleoplasmic lamin pool in chromatin orga-
ization, cell signaling and cell cycle control in adult tissue stem
ells (ASCs). In this review we discuss the potential functions of
ucleoplasmic A-type lamins in ﬁne-tuning the balance between
roliferation and differentiation of ASCs, which is of crucial impor-
ance for tissue homeostasis. We  also discuss how nucleoplasmic
-type lamins may  affect the regulation of stem cell activity and
ow these functions may  be altered in lamin-linked diseases.
. Interplay between A-type lamins and LAP2
Lamina-associated polypeptide 2  (LAP2)  is one of six splice
ariants of the mammalian LAP2 gene (originally termed TMPO)
25–28]. All LAP2 isoforms share the ﬁrst 187 N-terminal residues
29] harboring the LAP2-Emerin-MAN1 (LEM)-domain [30], which
ediates interaction with DNA in a sequence-independent man-
er via the adaptor protein barrier-to-autointegration factor (BAF)
31]. The common N-terminal LAP2 domain also contains a LEM-
ike motif enabling direct interaction with DNA [30,31]. Thus, all
AP2 proteins interact with chromatin by several mechanisms. The
-terminal domain of LAP2 differs considerably from that of the
ther LAP2 isoforms. Whereas most LAP2 isoforms, such as LAP2,
re stably anchored in the INM via a C-terminal transmembrane
omain, LAP2 is a non-membrane protein uniformly distributed
hroughout the nucleoplasm [32]. Furthermore, whereas the LAP2
embrane proteins primarily bind B-type lamins at the nuclear
amina [33], LAP2’s unique C-terminal tail mediates exclusive
inding to A-type lamins [22,24] and contains an additional chro-
osome association domain [34,35], as well as an interaction site
or the cell cycle and differentiation regulator, retinoblastoma pro-
ein (pRb) [36,37].
The speciﬁc interaction of A-type lamins and LAP2 has
een extensively studied by several means, including co-
mmunoprecipitation, cell cycle-dependent co-localization analy-
es and a proximity based biotin ligase assay in mammalian cells,
s well as by in vitro solid phase overlay and pull-down experi-
ents [22,32,38,39]. These studies revealed direct interaction ofpmental Biology 29 (2014) 116–124 117
lamins A/C and LAP2 via their C-terminal tails [22] and a dynamic
association of the proteins during the cell cycle. The nucleoplas-
mic  lamin A/C–LAP2 complexes exist in G1 and early S-phase of
proliferating cells but are absent during mitosis [32,40]. Intrigu-
ingly, LAP2 appears to be a crucial factor for the regulation and
stabilization of the nucleoplasmic pool of lamin A/C and its local-
ization in the nuclear interior (Fig. 1). In cells and epithelial tissues
derived from LAP2-deﬁcient mice, A-type lamins localize exclu-
sively to the nuclear lamina and are absent from the nuclear
interior. Re-expression of full length LAP2, but not of a lamin
binding-defective LAP2 mutant, into LAP2-deﬁcient cells res-
cues the nucleoplasmic pool of lamin A/C [24]. Furthermore, loss
of the nucleoplasmic pool of A-type lamins during myoblast differ-
entiation correlates with the downregulation of LAP2 [41].
Therefore, LAP2 is a master regulator of the nucleoplasmic
lamin A/C pool, but the mechanisms by which LAP2 affects nucle-
oplasmic lamins remain elusive. In G1 phase of the cell cycle,
nucleoplasmic A-type lamins may  originate from lamin complexes
disassembled in the preceding mitosis, or may represent newly
synthesized pre-lamin A, which may  interact with LAP2 in the
nucleoplasm only transiently, before they assemble into the nuclear
lamina. The most intriguing scenario, however, is that A-type
lamins are dynamically exchanged between the peripheral and the
nucleopasmic pool, depending on post-translational modiﬁcations
and/or the interaction of LAP2 and other factors.
3. Role of A-type lamins in disease
In 1999, Bonne et al. described the ﬁrst mutation in the LMNA
gene linked to autosomal dominant Emery Dreifuss muscular dys-
trophy (EDMD) [42]. Since then about 400 disease-linked mutations
were identiﬁed in A-type lamins and in several lamin-binding pro-
teins of the nuclear envelope.
These mutations cause a variety of diseases, collectively termed
primary laminopathies for lamin A/C-linked diseases and nuclear
envelopathies for diseases linked to nuclear envelope proteins They
affect different tissues (striated muscle, heart, fat, bone, skin, or
neuronal tissues) in isolation or in various combinations, or cause
premature aging diseases, e.g., Hutchinson–Gilford Progeria Syn-
drome (HGPS) [43–47].
Also a mutation in LAP2  ˛ has been linked to dilated cardiomy-
opathy (DCM) [39], the pathological features of which resemble
those of lamin A-linked DCM. Interestingly, this DCM-causing
LAP2 mutation, which leads to a single amino acid exchange in
the C-terminal lamin A/C-binding domain of LAP2 was shown to
impair LAP2’s interaction with lamin A/C in vitro [39].
Most disease-causing mutations in the LMNA gene are heterozy-
gous single point mutations in LMNA found throughout the gene,
leading to the expression of mutant lamin A/C variants with a sin-
gle amino acid exchange. In contrast, the majority of mutations
linked to HGPS introduce a cryptic splice site in exon 11 of LMNA,
causing incorrect splicing and generation of a slightly smaller pre-
lamin A variant (called progerin) that cannot be cleaved in the ﬁnal
step of post-translational processing and therefore remains perma-
nently farnesylated [48]. Given that A-type lamins are expressed
in nearly every differentiated cell, the tissue-speciﬁc phenotypes
of many laminopathies are surprising, and the molecular pathways
leading to the different pathological phenotypes are still not under-
stood. Several non-mutually exclusive disease mechanisms have
been proposed to explain the tissue-speciﬁc aspects and variability
of laminopathic phenotypes [49,50].3.1. The mechanical model
LMNA mutations may  disrupt the stability or assembly of lamin
networks, rendering the nucleus more fragile and less resistant
118 K. Gesson et al. / Seminars in Cell & Developmental Biology 29 (2014) 116–124
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aig. 1. LAP2 facilitates translocation of A-type lamins to the nucleoplasm. Peripher
egulate chromatin organization.
o mechanical stress, ultimately leading to structural damage and
ell death in mechanically stressed tissues [51]. This model is
upported by reports that lamin A/C-deﬁcient ﬁbroblasts, as well
s cells derived from several laminopathy patients have abnor-
ally shaped nuclei [52–54], and skeletal muscle from EDMD
atients and mouse disease models exhibit fragmented nuclei
55,56]. Biomechanical studies showed that, unlike B-type lamins,
amins A/C are the primary contributors to nuclear mechan-
cs [54,57]. Accordingly, lamin A/C-deﬁcient ﬁbroblasts show
ecreased nuclear and cytoskeletal mechanical stiffness, increased
uclear fragility and impaired activation of mechanosensitive
enes [58–61]. Mutations in A-type lamins can also disrupt nucleo-
ytoskeletal coupling, leading to a disturbance of nuclear anchorage
nd impaired ability to transmit intracellular forces between the
ytoskeleton and nuclear interior [51,62]. Therefore, the mechan-
cal model may  best describe muscular-dystrophy laminopathies,
s muscles are exposed to high physical forces. For instance, cells
xpressing Familial Partial Lipodystrophy (FPLD)-linked lamin A/C
utants have normal nuclear stiffness, while mutations linked to
DMD and DCM result in a loss of nuclear stability [51].
.2. The gene regulation model
This model proposes that mutations in A-type lamins or their
ssociated proteins cause dysregulation of tissue-speciﬁc genes
46]. The altered regulation of genes may  be caused by the
mpairment of heterochromatin formation and epigenetic path-
ays found in many laminopathic cells and in Lmna−/− mouse
ells [63–65]. Lamins can also affect signaling and gene expres-
ion by direct interactions with transcription factors and signaling
olecules. In particular, signaling pathways involved in the reg-
lation of proliferation and differentiation have been found to be
ffected in laminopathies, including pRb, mitogen activated pro-
ein kinase (MAPK), Notch, transforming growth factor  (TGF-),
terol response element binding protein-1 (SREBP-1), NF-B and
nt/-catenin pathways [4,10]. In support of this notion, cells
nd tissues derived from EDMD and DCM mouse models andype lamins and nucleoplasmic A-type lamins, alone or in complex with LAP2, may
patients show upregulated MAPK signaling [66], and HGPS patient
cells present defective Wnt-, Notch- and pRb signaling [67–69]. In
addition, in mouse models for progeria, NF-B signaling was  con-
stitutively hyperactivated, leading to upregulation of inﬂammatory
cytokines [70]. Lamin A/C-deﬁcient cells show impaired activation
of mechanosensitive genes (Egr1, lex1 and Mlk1) and decreased NF-
B signaling [59,60,71], thus potentially linking the mechanical and
gene regulation disease models.
3.3. The stem cell model
At the cellular level, this model proposes that mutations in
LMNA result in proliferation and differentiation defects, which may
well be directly linked to the mechanic and/or gene regulation
defects mentioned above. This model is based on ﬁndings that
A-type lamins interact functionally with two  important regula-
tors of G1 to S phase cell cycle progression, pRb and cyclin D3
[37,72,73] (see Section 4.1). Human HGPS ﬁbroblasts show rapid
growth at early passages, but undergo premature senescence at
higher passage numbers [74], and murine progeria ﬁbroblasts also
undergo premature cellular senescence [75]. Both, mesenchymal
stem cells expressing progerin [76] and epidermal stem cells in skin
of progeria mice [67] display impaired proliferation and/or differ-
entiation. Loss of wild-type lamin A/C or the expression of EDMD
lamin A/C mutants compromise myoblast differentiation [77,78],
and overexpression of wild-type lamin A or FPLD-linked lamin A
mutants affect adipocyte differentiation [79]. Lamins A/C appear
to be involved also in osteoblast differentiation, as knock-down
of lamin A/C caused impaired osteoblastogenesis and accelerated
osteoclastogenesis in human bone marrow stromal cells [80,81].
4. Functions of nucleoplasmic lamin A/C–LAP2 complexes
and their link to diseaseTo date, only a handful of studies have addressed the potential
functions of nucleoplasmic A-type lamins as opposed to those of
lamins at the nuclear periphery. However, many of the described
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unctions of lamins, which intrinsically have been linked to the
eripheral lamina, may  partly or predominantly require their pres-
nce within the nucleus. It is plausible to assume that, similar to the
amina, nucleoplasmic lamin A/C complexes can serve as a scaffold
or signaling molecules [4,82] and may  contribute to chromatin
rganization and epigenetic regulation of genes in the nuclear
nterior [83]. They may  even contribute to nuclear mechanics
y stabilizing an intranuclear meshwork that absorbs mechanical
orces evenly like a sponge [60].
As in classical lamin A/C knock-out experiments or by expres-
ion of mutant versions of lamin A/C both lamin pools are likely to
e affected, it is difﬁcult to distinguish between peripheral versus
ucleoplasmic lamin functions. Hence, the LAP2 knock-out mice,
isplaying signiﬁcantly reduced levels of nucleoplasmic lamins A/C,
rovide an experimental system to selectively study the functions
f A-type lamins in the nuclear interior [24].
.1. Nucleoplasmic LAP2˛–lamin A/C complexes in proliferation
nd differentiation
Both LAP2 [36,37] and lamins A and C [84,85] bind pRb in
itro and in vivo. pRb is a major cell cycle regulator that represses
he activity of E2F transcription factors and thereby inhibits cell
ycle progression in a phosphorylation-dependent manner [86].
n the absence of mitogenic signals or upon differentiation, pRb
s hypo-phosphorylated, binds to E2F and inhibits E2F target gene
ranscription, allowing cells to exit the cell cycle. In the presence
f mitogenic signals, pRb is heavily phosphorylated by cyclin-
ependent kinases, causing release from E2F transcription factors,
ctivation of E2F-dependent transcription and cell cycle progres-
ion. This basic pRb cell proliferation-regulating cycle is subject to
urther control by many additional pathways and feedback loops,
ome of which may  also include nucleoplasmic A-type lamins.
Several mechanisms have been proposed to explain how nucleo-
lasmic lamin A/C and LAP2 affect pRb function (Fig. 2): (i) A-type
amins may  stabilize pRb protein, since pRb was  degraded via the
roteosomal pathway in lamin A/C-deﬁcient cells [72]. (ii) A-type
amins may  provide a scaffold for efﬁcient dephosphorylation of
Rb by PP2A protein phosphatase upon TGFß-induced cell cycle
rrest [87]. (iii) Interaction of pRb with A-type lamins may  keep pRb
n its active (repressive) hypo-phosphorylated state. Upon growth
timulation, ERK kinase translocates to the nucleus and may  com-
ete with pRb for binding to lamins A/C, causing release of pRb and
ts efﬁcient phosphorylation by cyclin-dependent kinases [88]. (iv)
 complex of LAP2, lamin A/C and hypo-phosphorylated pRb [37]
ay  be involved in efﬁcient E2F target gene repression [36].
In accordance with these mechanisms, nucleoplasmic lamins
/C and LAP2 were found to negatively affect cell cycle progres-
ion and thus enhance cell cycle arrest in tissue progenitor cells of
egenerating tissues. Overexpression of LAP2 in cultured murine
re-adipocytes drives cells into cell cycle exit and initiates differen-
iation in the absence of hormones [36]. In contrast, loss of LAP2
mpairs efﬁcient cell cycle exit by contact inhibition in primary
urine ﬁbroblasts [24]. LAP2-deﬁcient myoblasts express higher
evels of stemness factors compared to wild-type cells and show
elayed differentiation in vivo [89]. Correspondingly, in LAP2-
eﬁcient mice, the number of proliferating tissue progenitor cells
as signiﬁcantly increased in skin, colon, skeletal muscle, and in the
ematopoietic system [24,40,89,90]. Furthermore, loss of LAP2 in
amin A/C-deﬁcient mice, which lack wild-type lamin A but express
ow levels of a lamin A 8–11 variant in some cells and tissues
91], prolonged life span of double mutant mice from 30 to 70 days
nd partially rescued the muscle growth phenotype [92], proba-
ly by promoting proliferation of muscle progenitor cells. These
ndings suggest that nucleoplasmic lamin A/C–LAP2 complexes
ermit and/or promote differentiation of tissue progenitor cells andpmental Biology 29 (2014) 116–124 119
may  thus be involved in tissue homeostasis by controlling the bal-
ance between proliferation and differentiation of adult stem cells
as described in the following section.
4.2. Lamins in stem cell regulation
A-type lamins are absent or expressed at very low levels in
undifferentiated embryonic stem cells (ESCs), and are upregulated
only during cell differentiation [93,94]. Furthermore, upon repro-
gramming of somatic ﬁbroblasts to induced pluripotent stem (iPS)
cells, lamin A levels are vastly decreased. Knockdown of lamin
A during reprogramming facilitates iPS cell generation, whereas
overexpression inhibits the induction of pluripotency and drives
differentiation [95].
While A-type lamins may  be less important for initiation of ES
cell differentiation, they may  have important regulatory roles in
somatic (adult) stem cells (ASCs). These are tissue-speciﬁc stem
cells which serve as a clonogenic, self-renewing reservoir with the
capability to differentiate into multiple cell lineages and are respon-
sible for maintaining tissue homeostasis in adult organism by
replenishing dying and non-functional cells [96]. Adult stem cells
include hematopoietic and mesenchymal stem cells (MSCs). MSCs
differentiate to committed precursor cells important for the regen-
eration of muscle, heart, bone, adipose, nerve and skin tissue, all
of which are severely affected in different laminopathies. There is
evidence that A-type lamins are important for regulating the main-
tenance and differentiation of both MSCs and tissue progenitor
cells by inﬂuencing key signaling pathways [49,97]. Downregu-
lation of A-type lamins or expression of HGPS lamin A variant
in MSCs affects osteogenic, chondrogenic and adipogenic differ-
entiation [76,81,98]. Furthermore, in two  different HGPS mouse
models, epidermal stem cells were depleted causing an inﬂam-
matory response [67,99]. Muscle-derived stem/progenitor cells
(MDPSCs) from progeria mice also displayed defective proliferation
and differentiation [100]. Interestingly, intraperitoneal administra-
tion of MDPSCs derived from young wild-type mice to progeroid
mice leads to signiﬁcant extension of lifespan, suggesting that
impaired MDPSC function in progeria mice results in a reduced life
expectancy.
Altogether, the ﬁndings that lamins alter adult stem cell function
led to the hypothesis that at least part of the phenotypes observed
in laminopathies are due to defects in stem cell-mediated tissue
regeneration [49,101]. Increased turnover and abnormal differenti-
ation of adult stem cells in laminopathies may  also deplete the stem
cell pool. The stem cell defect, coupled with a potentially increased
mechanical sensitivity, could result in an inefﬁcient repair of dam-
aged tissues in HGPS and other laminopathies [101–103].
4.3. Impaired proliferation/differentiation pathways in
laminopathies
Many mutations linked to laminopathies affect the localization
of A-type lamins, either increasing or decreasing the nucleoplasmic
pool of A-type lamins or leading to aggregation of mutant lamins
in the nucleoplasm [104–107]. Therefore, it is conceivable that at
least some of the molecular defects underlying laminopathies are
linked to a misregulation of the functions of nucleoplasmic lamins
A/C. Based on the role of nucleoplasmic lamins A/C and LAP2 in
pRb-mediated cell cycle control (Fig. 2), it is tempting to speculate
that mutations in these proteins affect pRb-mediated pathways and
derail the balance between proliferation/self-renewal and differ-
entiation of tissue progenitor cells. EDMD- or HGPS-linked lamin A
mutants impair phosphorylation of pRb [41,108], which may  lead
to premature cell cycle exit and senescence and to the inhibition
of differentiation [109,110]. In addition, pRb is downregulated in
the Zinc metalloproteinase Ste24 homolog (Zmpste24)−/− progeria
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ifferentiation of adult stem cells. Disease linked perturbations of lamins A/C and/o
ouse model [111], and genome-wide expression analysis identi-
ed the lamin A-pRb signaling network as a major pathway affected
n HGPS [69]. Also the abnormal pRb localization in laminopathies
112] could further contribute to pRb dysregulation.
Besides its role in cell cycle control, pRb has well-established
unctions in the differentiation of muscle, adipose tissue, bone,
nd epidermis, all of which are affected in laminopathies. The
Rb/MyoD pathway is the master regulator of myogenesis in skele-
al muscle. pRb interacts with the myogenic transcription factor
yoD, subsequently activating MyoD-target genes and thereby
nitiating myoblast differentiation [113]. Thus, defects of the pRb
athway in laminopathies may  not only affect cell cycle exit, but
ay also impair pRb’s role in differentiation [103]. In line with
his model, Lmna-deﬁcient skeletal myocytes express lower levels
f MyoD protein and consequently exhibit impaired MyoD/Rb-
ediated in vitro myogenesis [77,78].
Besides pRb pathways, other differentiation-mediating signal-
ng pathways were shown to be affected in mutant cells and
issues. The aberrant differentiation of MSCs ectopically expressing
rogerin was linked to increased Notch signaling [76]. Wild-type
amin A associates with the Notch co-activator SKIP, thereby
cavenging SKIP and reducing Notch-dependent transcriptional
ctivity. Progerin has reduced afﬁnity for SKIP leading to anveral mechanisms (for details see text) balancing proliferation/self-renewal and
 may result in an imbalance between these two cell fates.
increase in SKIP availability and activation of Notch downstream
effectors. Moreover, the Wnt/-catenin pathway, which is known
to promote stem cell proliferation in stem-cell niches of the
intestine, bone marrow, brain, and epidermis, was found to be
attenuated in HGPS mouse models, altering extracellular matrix
production [68].
5. Lamins in chromatin organization and implication for
laminopathies
Chromatin is non-randomly organized in the nucleus through
formation of chromosome territories [114] and associations with
the NE/nuclear lamina and possibly other structural components in
the nucleus [7,115,8]. A-type lamins have long been proposed to be
involved in the spatial organization of chromatin due to their ability
to interact with DNA and core histones [11]. Similarly, several lamin
binding proteins, including Lamin B Receptor (LBR) and the LEM
proteins [15,30] have been shown to interact with chromatin. How-
ever, only recently a few studies revealed two  redundant pathways
tethering chromatin to the periphery, an LBR-mediated anchor-
age (probably involving B-type lamins) and an A-type lamin-LEM
protein-dependent mechanism [116,117].
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.1. The role of the nuclear lamina in chromatin organization and
ene expression
The implementation of the DamID method using a DNA adenine
ethyltransferase (Dam)-lamin B1 fusion protein led to the ﬁrst
enome-wide map  of in vivo nuclear lamina–chromatin interac-
ions [118,119]. The identiﬁed lamina-associated domains (LADs)
ere shown to be large-scale, yet sharply conﬁned genomic regions
f 0.1–10 Mb  in size, which have transcriptional repressive fea-
ures and represent gene-poor and heterochromatic regions with
igniﬁcant enrichments of repressive histone marks (H3K27me3,
3K9me3) [120]. This led to the concept that the nuclear periphery
s an overall transcriptionally repressive environment as opposed
o the transcriptionally permissive conditions in the nucleoplasm
83]. This model was supported by experiments showing that
rtiﬁcial tethering of genomic loci to the NE leads, at least in
ome cases, to their silencing [121–123]. Furthermore, genome-
ntegrated arrays containing tissue-speciﬁc promoters were found
o localize at the periphery in embryos and translocated to the
uclear center upon differentiation-dependent promoter activa-
ion [124]. Additionally, a lamin B1-DamID approach tracking
amina–chromatin interactions during differentiation of murine
SCs to neuronal precursor cells and to terminally differentiated
strocytes showed that previously stably NE-associated genes or
ene clusters detach from the NE and subsequently become acti-
ated during differentiation [125]. These experiments indicated
hat the NE not only anchors heterochromatin, but may  also actively
ontribute to the generation of a heterochromatic, transcriptionally
ilent environment. However, detachment from the NE per se does
ot necessarily trigger immediate activation, but may  poise genes
or later activation during terminal differentiation.
Opposing the view that NE–chromatin interactions are stable in
he sense that they are inherited from mother to daughter cells, a
ecent study showed that in a given cell only 30% of all LADs are
ssociated with the NE and are stochastically reshufﬂed after mito-
is [126]. It remains to be investigated whether LADs containing
issue-speciﬁc genes are more speciﬁcally tethered to the NE during
ifferentiation. Also, the “signature” (i.e., the epigenetic and genetic
roﬁle) of chromatin mediating its association at the NE is poorly
nderstood. A few recent studies have identiﬁed the heterochro-
atic histone mark, H3K9me2 [126,127], A/T rich sequences [128],
r GAGA motifs [129] as important determinants for chromatin–NE
ethering.
.2. A-type lamins and chromatin regulation
Considering the dual location of A-type lamins at the nuclear
amina and in the nucleoplasm, as opposed to the exclusive periph-
ral localization of B-type lamins, it is conceivable that A-type
amins may  also interact with chromatin in the nuclear interior
Fig. 1). At the NE, certain chromatin attachment regions may
e common for both A- and B-type lamins, while other genomic
egions may  be exclusive to one or the other. In support of this,
himi et al. found that A- and B-type lamins form distinct, but inter-
onnected, networks at the nuclear lamina [130]. While the term
LAD” was originally coined for lamin B1–chromatin interactions,
t appears to be extendable toward the association of lamin A with
hromosomes at the NE. Genomic DamID maps for lamin A–Dam
usion proteins in human and murine cells are very similar to the
enomic lamin B1 DamID maps, and constitutive NE–chromatin
ssociations (cLADs) are highly conserved across species and cell
ypes [128]. In addition to regions generally not associated with
he lamina (constitutive inter-LADs), certain regions were found to
acultatively interact with A- and B-type lamins in the course of
ineage commitment, and do so with a potential preference for one
r the other lamin type [128].pmental Biology 29 (2014) 116–124 121
A recent study by Kubben et al. [131] shed light on the in vivo
chromatin interactions of wildtype versus mutant lamin A linked
to HGPS (progerin). In a genome-wide analysis of promoter inter-
actions, they showed a preference of A-type lamins for binding to
promoters of silent or lowly expressed genes preferentially located
at the nuclear periphery. Progerin–promoter interactions over-
lapped to a large extent with that of wild-type lamin A, but a few
progerin-speciﬁc (inherently silent) gene promoters were iden-
tiﬁed. This extensive overlap of wildtype lamin A and progerin
promoter interactions is surprising, given that progerin appears to
have reduced binding afﬁnity to DNA and H3K27 trimethylated his-
tones [132]. While the former study used overexpressed lamin A
and progerin, genome interaction mapping of endogenous lamin
A and progerin revealed global changes in the heterochromatic
mark H3K27me3, which appeared to be lost in gene-poor regions
in the mutant cells and appeared stronger in gene-rich regions,
resulting in the detachment from the nuclear lamina of gene-poor
heterochromatic regions [133].
Another recent study on genome-wide lamin A/C-promoter
association during adipogenic differentiation identiﬁed lamin-rich
domains (LRDs) throughout the genome in a manner consistent
with lamin A/C–promoter interactions not being restricted to the
nuclear periphery [134]. Complementary to previous ﬁndings, this
study showed that binding of lamin A/C ﬁne-tunes target gene
regulation depending on the local chromatin environment in spe-
ciﬁc promoter subregions. The results indicate that lamin A/C
association with promoters per se does not inhibit transcription,
but additionally requires certain repressive histone marks in sub-
promoter regions; conversely, loss of lamin A/C from promoters is
a prerequisite, but not sufﬁcient for transcriptional activation.
LAP2 is a potential candidate for mediating the interaction of
nucleoplasmic lamins A/C with chromatin. LAP2 possesses a LEM
and LEM-like domain [30], and thereby binds to chromatin in a
sequence – independent manner. In human cells, LAP2 was found
to interact with genomic DNA in a highly dynamic manner and to
affect the chromatin-binding behavior of the high-mobility group
N protein 5 (HMGN5) [135]. Downregulation of LAP2 led to the
redistribution of HMGN5-targeted chromatin sites. Based on these
ﬁndings it is tempting to speculate that LAP2 could also affect the
chromatin interaction of other proteins in the nuclear interior, such
as nucleoplasmic lamin A/C.
In conclusion, A-type lamins not only ensure structural integrity
of (metazoan) nuclei, but also maintain the balance between dif-
ferentiation and proliferation. In part, these activities may  rely on
lamin A/C-binding proteins, such as LAP2. The potential effects of
laminopathy-linked lamin mutants on chromatin organization may
alter gene expression by destabilization of higher-order chromatin
structure and/or interference with the binding of A-type lamins to
other proteins. These perturbations may  particularly affect stem
cell homeostasis.
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